牛叉诊股

[{"date":"2026.08.19","stock":"0.51","trade":"-1.50","ind":"-5.01"},{"date":"2026.08.18","stock":"-0.60","trade":"-1.04","ind":"-0.56"},{"date":"2026.08.17","stock":"-0.46","trade":"0.49","ind":"2.44"},{"date":"2026.08.14","stock":"-0.85","trade":"-0.81","ind":"0.45"},{"date":"2026.08.13","stock":"-0.18","trade":"1.59","ind":"-0.87"},{"date":"2026.08.12","stock":"-0.55","trade":"0.14","ind":"1.09"},{"date":"2026.08.11","stock":"-0.70","trade":"0.34","ind":"-0.40"},{"date":"2026.08.10","stock":"0.85","trade":"0.39","ind":"0.04"},{"date":"2026.08.07","stock":"0.14","trade":"2.10","ind":"1.42"},{"date":"2026.08.06","stock":"-0.41","trade":"0.32","ind":"-0.24"},{"date":"2026.08.05","stock":"-1.55","trade":"-0.59","ind":"1.86"},{"date":"2026.08.04","stock":"-1.13","trade":"0.61","ind":"3.25"},{"date":"2026.08.03","stock":"-1.08","trade":"0.76","ind":"-0.96"},{"date":"2026.07.31","stock":"0.21","trade":"1.71","ind":"2.21"},{"date":"2026.07.30","stock":"1.66","trade":"-0.93","ind":"-2.73"},{"date":"2026.07.29","stock":"0.89","trade":"0.54","ind":"1.10"},{"date":"2026.07.28","stock":"0.61","trade":"-0.02","ind":"-4.52"},{"date":"2026.07.27","stock":"0.24","trade":"3.54","ind":"2.72"},{"date":"2026.07.24","stock":"-1.35","trade":"-3.55","ind":"-2.47"},{"date":"2026.07.23","stock":"-0.10","trade":"0.55","ind":"0.44"},{"date":"2026.07.22","stock":"1.07","trade":"0.01","ind":"-1.42"}]

云南白药,深证成指,中药指数

压力支撑

该股压力位为49.74元，支撑位为49.47元。

[{"text":"\u538b\u529b\u4f4d","value":"49.74","date":1787068800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"49.47","date":1787068800,"color":"0x0b52a1"}]

多空趋势

空头行情中，目前反弹趋势有所减缓，投资者可适当关注。

macd kdj boll asi bias rsi wr vr

资金面诊股

诊断结果：4.7资金面打败了63%的股票主力控盘前10的股票

资金面得分最高的股票

主力控盘

据统计，近10日内主力筹码很集中，呈高度控盘状态。

没有控盘
轻度控盘
中度控盘
高度控盘

行业资金

中药行业，近5日资金流出较多，不建议投资者关注该行业的个股。

更新时间：08月19日 20:30

机构今日流向(万元)	-1530.37	机构5日流向(万元)	-6172.38
机构10日流向(万元)	-9293.24	机构20日流向(万元)	-13417.53

机构持仓

2026-06-30 与 2025-12-31 相比，主力机构持仓量减少123608.55万股，其中基金净增仓12家，主力净减仓516家，暂未发现中长期投资价值。

截止2026-06-30，共50家主力机构（基金50家），持仓量总计3878.54万股，占流通A股2.19%
其中，基金持仓与2025-12-31相比：
增仓：23家，增持 834.36万股
减仓：11家，减持 78.43万股
新出现在主力名单中：14家，持有291.84万股
从主力名单中消失：530家，原持有124656.32万股

消息面诊股

诊断结果：5.5消息面打败了14%的股票今日有利好新闻的公司

近期该股消息面总体多空平衡，没有较强的利好或利空趋势。

消息面得分最高的股票

消息列表

一般消息	重大事项	关联交易	2026-04-22
一般消息	股东大会	年度股东大会	2026-04-01
利好	分红转增	10派15.83元(含税)	2026-04-01
一般消息	重大事项	关联交易	2026-04-01
一般消息	重大事项	公司股东股份解押	2026-03-25
一般消息	重大事项	公司股东股份解押	2026-02-26
一般消息	高管变动	达到法定退休年龄	2026-02-10
一般消息	重大事项	公司股东股份解押	2026-02-04
利好	重大事项	参股拟上市公司或非上市公司金融机构	2025-12-31
一般消息	高管变动	取消监事会	2025-11-10
一般消息	重大事项	公司股东股份解押	2025-10-29
利好	分红转增	10派10.19元(含税)	2025-08-30

一年消息统计

	所有消息	重大消息	非重大消息
利好	3条	0条	3条
利空	0条	0条	0条

行业面诊股

诊断结果：7.5行业面打败了91%的股票中药行业最新资金流向

近10日来该行业走势不明显，明显跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

行业面得分最高的股票

行业走势

近10日来该行业走势不明显，明显跑赢大盘。

[{"date":"2026.08.19","price":"-5.01","value":"-1.50"},{"date":"2026.08.18","price":"-0.56","value":"-1.04"},{"date":"2026.08.17","price":"2.44","value":"0.49"},{"date":"2026.08.14","price":"0.45","value":"-0.81"},{"date":"2026.08.13","price":"-0.87","value":"1.59"},{"date":"2026.08.12","price":"1.09","value":"0.14"},{"date":"2026.08.11","price":"-0.40","value":"0.34"},{"date":"2026.08.10","price":"0.04","value":"0.39"},{"date":"2026.08.07","price":"1.42","value":"2.10"},{"date":"2026.08.06","price":"-0.24","value":"0.32"},{"date":"2026.08.05","price":"1.86","value":"-0.59"},{"date":"2026.08.04","price":"3.25","value":"0.61"},{"date":"2026.08.03","price":"-0.96","value":"0.76"},{"date":"2026.07.31","price":"2.21","value":"1.71"},{"date":"2026.07.30","price":"-2.73","value":"-0.93"},{"date":"2026.07.29","price":"1.10","value":"0.54"},{"date":"2026.07.28","price":"-4.52","value":"-0.02"},{"date":"2026.07.27","price":"2.72","value":"3.54"},{"date":"2026.07.24","price":"-2.47","value":"-3.55"},{"date":"2026.07.23","price":"0.44","value":"0.55"},{"date":"2026.07.22","price":"-1.42","value":"0.01"}]

深证成指,中药行业

行业排名

排名	股票名称	1月涨跌幅	5日涨跌幅	评分
1	陇神戎发	38.69%	16.61%	5.1分
2	华森制药	29.82%	17.80%	6.2分
3	粤万年青	28.53%	13.64%	5.6分
4	三力制药	26.99%	0.08%	5.3分
5	汉森制药	25.48%	15.34%	6.1分
6	维康药业	21.90%	-6.20%	6.2分
7	益盛药业	17.35%	-0.44%	5.3分
8	新天药业	16.30%	1.32%	5.8分
9	新光药业	16.13%	2.18%	5.3分
10	太龙药业	16.05%	3.18%	6.0分
11	恩威医药	15.72%	2.06%	5.7分
12	华神科技	14.33%	-0.73%	5.9分
13	古汉医药	12.66%	-2.33%	4.8分
14	振东制药	11.96%	-6.06%	5.1分
15	ST嘉应	9.36%	-5.22%	4.6分
16	方盛制药	8.45%	3.58%	5.5分
17	特一药业	8.00%	-0.43%	5.3分
18	佛慈制药	7.92%	2.25%	5.4分
19	益佰制药	7.58%	-1.29%	5.4分
20	ST葫芦娃	6.96%	-3.95%	5.0分
21	康惠股份	6.60%	-3.71%	5.0分
22	亚宝药业	6.55%	0.87%	5.7分
23	沃华医药	6.51%	0.16%	6.3分
24	精华制药	6.03%	1.15%	5.9分
25	*ST香雪	5.32%	-6.22%	4.4分
26	ST金花	3.78%	-5.66%	4.8分
27	信邦制药	3.75%	-2.25%	5.5分
28	中恒集团	3.72%	-3.04%	4.8分
29	寿仙谷	3.30%	-2.97%	5.2分
30	-	2.71%	-5.56%	分
31	千金药业	2.70%	-0.40%	5.9分
32	红日药业	2.10%	-2.57%	4.9分
33	ST万邦	2.09%	-12.79%	5.7分
34	仁和药业	2.07%	-0.37%	5.3分
35	马应龙	1.80%	-1.15%	5.3分
36	九芝堂	1.76%	-1.49%	5.8分
37	ST百灵	1.36%	-3.66%	5.0分
38	康恩贝	1.16%	-8.42%	5.6分
39	桂林三金	0.99%	-0.15%	6.1分
40	盘龙药业	0.95%	1.31%	5.3分
41	东阿阿胶	0.58%	-2.32%	4.9分
42	佐力药业	0.49%	-0.83%	5.7分
43	葵花药业	0.38%	-1.49%	5.5分
44	康美药业	0.00%	-6.25%	3.6分
45	昆药集团	-1.03%	-8.09%	4.5分
46	珍宝岛	-1.18%	-15.12%	4.2分
47	步长制药	-1.64%	-1.95%	5.3分
48	众生药业	-2.05%	-2.58%	5.6分
49	华润三九	-2.19%	-1.44%	5.5分
50	上海凯宝	-2.26%	-2.60%	5.0分
51	健民集团	-2.48%	-4.61%	5.6分
52	奇正藏药	-2.71%	-2.57%	5.1分
53	吉林敖东	-2.89%	-1.77%	4.9分
54	太极集团	-3.39%	-4.29%	4.3分
55	云南白药	-3.86%	-1.58%	5.5分
56	天目药业	-3.86%	-4.04%	4.8分
57	康缘药业	-4.11%	-1.98%	4.9分
58	以岭药业	-4.23%	-1.61%	5.5分
59	白云山	-4.40%	-2.00%	4.9分
60	天士力	-4.75%	-0.46%	5.2分
61	华润江中	-4.80%	-0.91%	5.1分
62	达仁堂	-5.41%	-2.91%	5.1分
63	-	-6.45%	3.85%	分
64	同仁堂	-7.43%	-3.30%	4.5分
65	广誉远	-7.63%	-3.90%	5.0分
66	片仔癀	-8.04%	-5.76%	4.9分
67	济川药业	-9.57%	-1.39%	5.2分
68	羚锐制药	-10.93%	-2.44%	5.2分

<上一页 1 2 3 4 5...12 下一页>

行业评级

最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。

综合评级

研究机构	评级日期	最新评级	上次评级
中信证券	2012-09-10	增持	增持
招商证券	2012-09-08	增持	增持
航天证券	2012-09-06	增持	-
中银国际	2012-09-05	增持	-
齐鲁证券	2012-09-05	增持	-

基本面诊股

诊断结果：7.1基本面打败了91%的股票连续3年业绩增长30%的公司

该公司运营状况良好，多数机构认为该股长期投资价值较高。

个股深一度

潜在高分红能力：强（100分）

基本面得分最高的股票

[ 截止日期：2026-03-31 ]公司经营

盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 9/108 ， 59/108。

[{"date":"2026-03-31","value":"4.96","vol":"2.21"},{"date":"2025-12-31","value":"13.07","vol":"-2.33"},{"date":"2025-09-30","value":"12.16","vol":"4.80"},{"date":"2025-06-30","value":"9.17","vol":"4.03"},{"date":"2025-03-31","value":"4.86","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净资产收益率(%)	4.96	13.07	12.16	9.17	4.86
行业(%)	2.21	-2.33	4.80	4.03	2.24

该指标值越高，盈利能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"30.63","vol":"55.05"},{"date":"2025-12-31","value":"29.51","vol":"52.85"},{"date":"2025-09-30","value":"30.06","vol":"53.29"},{"date":"2025-06-30","value":"30.86","vol":"53.82"},{"date":"2025-03-31","value":"31.55","vol":"54.48"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
销售毛利率(%)	30.63	29.51	30.06	30.86	31.55
行业(%)	55.05	52.85	53.29	53.82	54.48

该指标值越高，盈利能力越强，行业排名越靠前。

成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 16/108 ， 32/108。

[{"date":"2026-03-31","value":"7.02","vol":"-5.58"},{"date":"2025-12-31","value":"2.88","vol":"-6.76"},{"date":"2025-09-30","value":"2.47","vol":"-7.84"},{"date":"2025-06-30","value":"3.92","vol":"-7.78"},{"date":"2025-03-31","value":"0.62","vol":"-7.40"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
营业收入同比增长率(%)	7.02	2.88	2.47	3.92	0.62
行业(%)	-5.58	-6.76	-7.84	-7.78	-7.40

该指标值越高，成长能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"5.31","vol":"1.06"},{"date":"2025-12-31","value":"8.51","vol":"-80.25"},{"date":"2025-09-30","value":"10.41","vol":"-2.78"},{"date":"2025-06-30","value":"13.93","vol":"2.25"},{"date":"2025-03-31","value":"13.67","vol":"-37.69"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
净利润同比增长率(%)	5.31	8.51	10.41	13.93	13.67
行业(%)	1.06	-80.25	-2.78	2.25	-37.69

该指标值越高，成长能力越强，行业排名越靠前。

营运能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/108 ， 5/108。

[{"date":"2026-03-31","value":"0.21","vol":"0.12"},{"date":"2025-12-31","value":"0.77","vol":"0.47"},{"date":"2025-09-30","value":"0.58","vol":"0.35"},{"date":"2025-06-30","value":"0.40","vol":"0.24"},{"date":"2025-03-31","value":"0.20","vol":"0.13"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
总资产周转率(次)	0.21	0.77	0.58	0.40	0.20
行业(次)	0.12	0.47	0.35	0.24	0.13

该指标值越高，营运能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"1.30","vol":"0.59"},{"date":"2025-12-31","value":"4.64","vol":"2.34"},{"date":"2025-09-30","value":"3.55","vol":"1.72"},{"date":"2025-06-30","value":"2.42","vol":"1.17"},{"date":"2025-03-31","value":"1.21","vol":"0.59"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
存货增长率(次)	1.30	4.64	3.55	2.42	1.21
行业(次)	0.59	2.34	1.72	1.17	0.59

该指标值越高，营运能力越强，行业排名越靠前。

现金流能力：数据暂时不全，请后续关注

[{"date":"2026-03-31","value":"7.15","vol":"5.83"},{"date":"2025-12-31","value":"1.36","vol":"30.77"},{"date":"2025-09-30","value":"5.27","vol":"10.53"},{"date":"2025-06-30","value":"31.18","vol":"22.82"},{"date":"2025-03-31","value":"6.58","vol":"2.06"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
现金流量净额/营业收入	7.15	1.36	5.27	31.18	6.58
行业	5.83	30.77	10.53	22.82	2.06

该指标值越高，现金流能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.16","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.03","vol":"1.03"},{"date":"2025-03-31","value":"","vol":"0.00"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资本支出／折旧和摊销	-	1.16	-	1.03	-
行业	0.00	1.00	0.00	1.03	0.00

该指标值越低，现金流能力越强，行业排名越靠前。

短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 30/108 ， 43/108。

[{"date":"2026-03-31","value":"2.74","vol":"2.97"},{"date":"2025-12-31","value":"2.64","vol":"2.94"},{"date":"2025-09-30","value":"2.73","vol":"3.09"},{"date":"2025-06-30","value":"2.74","vol":"2.94"},{"date":"2025-03-31","value":"2.90","vol":"3.03"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
流动比率	2.74	2.64	2.73	2.74	2.90
行业	2.97	2.94	3.09	2.94	3.03

该指标值越接近2，短期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"2.16","vol":"2.23"},{"date":"2025-12-31","value":"2.03","vol":"2.15"},{"date":"2025-09-30","value":"2.10","vol":"2.24"},{"date":"2025-06-30","value":"2.12","vol":"2.15"},{"date":"2025-03-31","value":"2.27","vol":"2.24"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
速动比率	2.16	2.03	2.10	2.12	2.27
行业	2.23	2.15	2.24	2.15	2.24

该指标值越接近1，短期偿债能力越强，行业排名越靠前。

长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 36/108 ， 40/108。

[{"date":"2026-03-31","value":"25.31","vol":"31.94"},{"date":"2025-12-31","value":"26.02","vol":"32.43"},{"date":"2025-09-30","value":"25.36","vol":"31.59"},{"date":"2025-06-30","value":"25.73","vol":"32.45"},{"date":"2025-03-31","value":"24.81","vol":"31.91"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
资产负债率(%)	25.31	26.02	25.36	25.73	24.81
行业(%)	31.94	32.43	31.59	32.45	31.91

该指标值越接近50%，长期偿债能力越强，行业排名越靠前。

[{"date":"2026-03-31","value":"0.34","vol":"0.66"},{"date":"2025-12-31","value":"0.35","vol":"0.67"},{"date":"2025-09-30","value":"0.34","vol":"0.76"},{"date":"2025-06-30","value":"0.35","vol":"0.75"},{"date":"2025-03-31","value":"0.33","vol":"0.74"}]

	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
产权比率 (%)	0.34	0.35	0.34	0.35	0.33
行业(%)	0.66	0.67	0.76	0.75	0.74

该指标值越高，长期偿债能力越强，行业排名越靠前。

机构评级

最近60个交易日，机构评级以增持为主，认为该股票有一定投资价值。

研究机构	评级日期	最新评级	上次评级
财信证券	2026-07-27	增持
兴业证券	2026-07-26	增持
诚通证券	2026-07-13	增持
中信证券	2026-06-08	买入
国泰海通证券	2026-06-07	买入

机构预测

机构预测该股2026年每股收益与前一年相同，长期投资价值一般。

[{"date":"2022","yellowRectValue":"30.01","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"40.94","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"47.49","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"51.53","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"56.01","blueLineValue":"3.14","type":"YC"}]

[云南白药]

技术面诊股
资金面诊股
消息面诊股
行业面诊股
基本面诊股

【数据基于历史，不代表未来趋势；诊股基于模型与测试，需要投资者根据不同行情合理运用、独立判断、控制风险】

证券咨询服务提供：浙江同花顺云软件有限公司 [编号：zx0050]